Objective Chronic lymphocytic leukemia (CLL) is an adult leukemia presented with clonal
accumulation of lymphocytes. Immunophenotypic changes can be effective in predicting …

Background and purpose: Chronic lymphocytic leukemia (CLL) is characterized by clonal
proliferation and accumulation of long-lived B lymphocytes within the peripheral blood, bone …

Abstract Objective/Background From clinical and biological points of view, chronic
lymphocytic leukemia (CLL) is a heterogeneous disease characterized by a progressive …

Introduction: Chronic lymphoid leukemia (CLL) is a malignant proliferative disorder of
incompetent mature-looking lymphocytes that accumulate in peripheral blood (PB), bone …

Background Current chronic lymphocytic leukemia (CLL) International Prognostic Index (IPI)
stratifies patients based on clinical, molecular, and biochemical features; however, B‐cell …

SUMMARY Background: Chronic Lymphocytic Leukemia (CLL) is one of the most common
diagnoses made by flow cytome-try laboratories. There is no consensus on which markers …

Chronic lymphocytic leukemia (CLL) is the most common lymphoid hemopathy in elderly.
Diagnosis of CLL is easily made with a full blood count and immunophenotyping, but there …

Background Several markers have been proposed to predict the outcome of chronic
lymphocytic leukemia (CLL) patients. However, discordances exist between the current …

Background Chronic lymphocytic leukemia (CLL) is a B-lymphoproliferative disease with
varying clinical characteristics, which occurs mostly in older ages. In studies from literature …

Chronic lymphocytic leukemia (CLL) is a clinically and biologically heterogeneous disease
where the majority of patients have an indolent disease course, while others may …